Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · AktualisiertFlu Hospitalization Rate Week 18, 2026?
Flu Hospitalization Rate Week 18, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 Vol.
$17,846 Vol.
15. Mai 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 Vol.
$17,846 Vol.
15. Mai 2026
<80
$1,606 Vol.
No
80–85
$1,729 Vol.
No
85–90
$8,496 Vol.
Yes
90–95
$3,413 Vol.
No
95–100
$1,787 Vol.
No
100+
$815 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Markt eröffnet: May 8, 2026, 12:14 PM ET
Volumen
$17,846Enddatum
15. Mai 2026Markt eröffnet
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...Vorgeschlagenes Ergebnis: Yes
Kein Einspruch
Endgültiges Ergebnis: Yes
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$17,846Enddatum
15. Mai 2026Markt eröffnet
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...Vorgeschlagenes Ergebnis: Yes
Kein Einspruch
Endgültiges Ergebnis: Yes
Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Experimentelle KI-generierte Zusammenfassung mit Polymarket-Daten. Dies ist keine Handelsberatung und spielt keine Rolle bei der Auflösung dieses Marktes. · Aktualisiert
Vorsicht bei externen Links.
Vorsicht bei externen Links.
Häufig gestellte Fragen